Glucokinase diabetes in 103 families from a country-based study in the Czech Republic: Geographically restricted distribution of two prevalent GCK mutations

Pediatric Diabetes

Volumn 11, Issue 8, 2010, Pages 529-535

  Pruhova, Stepanka ^a,b   Dusatkova, Petra ^a   Sumnik, Zdenek ^a   Kolouskova, Stanislava ^a   Pedersen, Oluf ^c,d,e   Hansen, Torben ^c,f   Cinek, Ondrej ^a   Lebl, Jan ^a  

^a UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c HAGEDORN RESEARCH INSTITUTE   (Denmark)

^d AARHUS UNIVERSITY   (Denmark)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

^f UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

DHPLC; Diabetes; Founder effect; GCK MODY; Glucokinase

Indexed keywords

GLUCOKINASE; INSULIN; ORAL ANTIDIABETIC AGENT;

ARTICLE; CZECH REPUBLIC; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; GENE MUTATION; GENETIC ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; MATURITY ONSET DIABETES MELLITUS; PREVALENCE; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

ADOLESCENT; CHILD; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CZECH REPUBLIC; DIABETES MELLITUS, TYPE 2; GLUCOKINASE; HUMANS; MUTATION; PREVALENCE; PROTEIN DENATURATION; YOUNG ADULT;

EID: 78649803027     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/j.1399-5448.2010.00646.x     Document Type: Article

References (25)

1. Fajans SS, Bell GI, Polonsky KS. Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N Engl J Med 2001: 345: 971-980.
2. Velho G, Froguel P, Gloyn A, Hattersley AT. Maturity onset diabetes of the young type 2. In: Matschinsky FM, ed. Glucokinase and Glycemic Disease: From Basics to Novel Therapeutics. Basel: Kager, 2004, 42-64.
3. Estalella I, Rica I, Perez de Nanclares G et al. Mutations in GCK and HNF-1alpha explain the majority of cases with clinical diagnosis of MODY in Spain. Clin Endocrinol (Oxf) 2007: 67: 538-546.
4. Sagen JV, Bjorkhaug L, Molnes J, Raeder H, Grevle L, Sovik O et al. Diagnostic screening of MODY2/GCK mutations in the Norwegian MODY Registry. Pediatr Diabetes 2008: 9: 442-449.
5. Giuffrida FM, Reis AF. Genetic and clinical characteristics of maturity-onset diabetes of the young. Diabetes Obes Metab 2005: 7: 318-326.
6. Pruhova S, Ek J, Lebl J et al. Genetic epidemiology of MODY in the Czech republic: new mutations in the MODY genes HNF-4alpha, GCK and HNF-1alpha. Diabetologia 2003: 46: 291-295.
7. Stenson PD, Mort M, Ball EV et al. The human gene mutation database: 2008 update. Genome Med 2009: 1: 13.
8. Osbak KK, Colclough K, Saint-Martin C et al. Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia. Hum Mutat 2009: 30: 1512-1526.
9. Boutin P, Vasseur F, Samson C, Wahl C, Froguel P. Routine mutation screening of HNF-1alpha and GCK genes in MODY diagnosis: how effective are the techniques of DHPLC and direct sequencing used in combination? Diabetologia 2001: 44: 775-778.
10. Pinterova D, Ek J, Kolostova K et al. Six novel mutations in the GCK gene in MODY patients. Clin Genet 2007: 71: 95-96.
11. Ellard S, Bellanne-Chantelot C, Hattersley AT. Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young. Diabetologia 2008: 51: 546-553.
12. Lorini R, Klersy C, D'Annunzio G et al. Maturity-onset diabetes of the young in children with incidental hyperglycemia: a multicenter Italian study of 172 families. Diabetes Care 2009: 32: 1864-1866.
13. Schober E, Rami B, Grabert M et al. Phenotypical aspects of maturity-onset diabetes of the young (MODY diabetes) in comparison with type 2 diabetes mellitus (T2DM) in children and adolescents: experience from a large multicentre database. Diabet Med 2009: 26: 466-473.
14. Velho G, Blanche H, Vaxillaire M et al. Identification of 14 new glucokinase mutations and description of the clinical profile of 42 MODY-2 families. Diabetologia 1997: 40: 217-224.
15. Moises RS, Reis AF, Morel V et al. Prevalence of maturity-onset diabetes of the young mutations in Brazilian families with autosomal-dominant early-onset type 2 diabetes. Diabetes Care 2001: 24: 786-788.
16. Massa O, Meschi F, Cuesta-Munoz A et al. Diabetes Study Group of the Italian Society of Paediatric Endocrinology and Diabetes (SIEDP). High prevalence of glucokinase mutations in Italian children with MODY. Influence on glucose tolerance, first-phase insulin response, insulin sensitivity and BMI. Diabetologia 2001: 44: 898-905.
17. Hager J, Blanche H, Sun F et al. Six mutations in the glucokinase gene identified in MODY by using a nonradioactive sensitive screening technique. Diabetes 1994: 43: 730-733.
18. Ng MC, Cockburn BN, Lindner TH et al. Molecular genetics of diabetes mellitus in Chinese subjects: identification of mutations in glucokinase and hepatocyte nuclear factor-1alpha genes in patients with early-onset type 2 diabetes mellitus/MODY. Diabet Med 1999: 16: 956-963.
19. Ellard S, Thomas K, Edghill EL et al. Partial and whole gene deletion mutations of the GCK and HNF1A genes in maturity-onset diabetes of the young. Diabetologia 2007: 50: 2313-2317.
20. Garin I, Rica I, Estalella I et al. Haploinsufficiency at GCK gene is not a frequent event in MODY2 patients. Clin Endocrinol (Oxf) 2008: 68: 873-878.
21. Lukasova P, Vcelak J, Vankova M, Vejrazkova D, Andelova K, Bendlova B. Screening of mutations and polymorphisms in the glucokinase gene in Czech diabetic and healthy control populations. Physiol Res 2008: 57 (Suppl. 1): S99-S108.
22. Gasperikova D, Tribble ND, Stanik J et al. Identification of a novel beta-cell glucokinase (GCK) promoter mutation (-71G>C) that modulates GCK gene expression through loss of allele-specific Sp1 binding causing mild fasting hyperglycemia in humans. Diabetes 2009: 58: 1929-1235.
23. Forsyth L, Hume R, Howatson A, Busuttil A, Burchell A. Identification of novel polymorphisms in the glucokinase and glucose-6-phosphatase genes in infants who died suddenly and unexpectedly. J Mol Med 2005: 83: 610-618.
24. Christesen HB, Tribble ND, Molven A et al. Activating glucokinase (GCK) mutations as a cause of medically responsive congenital hyperinsulinism: prevalence in children and characterisation of a novel GCK mutation. Eur J Endocrinol 2008: 159: 27-34.
25. Johansen A, Ek J, Mortensen HB, Pedersen O, Hansen T. Half of clinically defined maturity-onset diabetes of the young patients in Denmark do not have mutations in HNF4A, GCK, and TCF1. J Clin Endocrinol Metab 2005: 90: 4607-4614.